The Germany In vitro fertilization market size is anticipated to reach USD 2.28 billion by 2030, growing at a CAGR of 5.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributable to the increasing cases of infertility, advanced medical technologies, increased awareness about infertility, and high success rates for IVF treatments. Factors such as delayed family planning, rising infertility rates, and societal acceptance of assisted reproductive technologies influence this growth.
The increasing age of parenthood is also driving the market, as more women delay childbirth due to career or personal reasons, potentially facing fertility issues that can be addressed through IVF treatments. Innovations in culture media formulations, particularly in cryopreservation, embryo culture, ovum processing, and sperm processing media, are expected to drive market growth, improving success rates and outcomes for assisted reproduction techniques.
The healthcare infrastructure, encompassing the presence of specialized clinics and skilled professionals, is crucial in shaping the market landscape. Furthermore, public awareness and societal acceptance of IVF as a viable solution for infertility contribute to the market's expansion, as individuals and couples increasingly seek these services to fulfill their reproductive aspirations. For instance, in April 2022, Berlin-based Apryl secured USD 4.1 million to launch a fertility benefits platform, aiming to provide inclusive employee benefits in the workplace, addressing rising fertility awareness and work-perk competition.
Request a free sample copy or view report summary: Germany In Vitro Fertilization Market Report
Culture media dominated the market with 41.1% share in 2023, owing to technological advancements, success rates, and outcomes for assisted reproduction techniques.
Based on procedure type, the frozen non donor segment dominated the market with the largest share in 2023. This is attributed to the flexibility in planning and scheduling of IVF cycles.
The fertility clinic segment accounted for the largest revenue share of 79.9% in 2023 and is expected to grow at the fastest CAGR during the forecast period owing to the increasing number of individuals and couples seeking fertility treatments.
Grand View Research has segmented the Germany In vitro fertilization market based on instrument, procedure type, and providers:
Germany In Vitro Fertilization Instrument Outlook (Revenue, USD Million, 2018 - 2030)
Disposable Devices
Culture Media
Cryopreservation Media
Embryo Culture Media
Ovum Processing Media
Sperm Processing Media
Equipment
Sperm Analyzer Systems
Imaging Systems
Ovum Aspiration Pumps
Micromanipulator Systems
Incubators
Gas Analyzers
Laser Systems
Cryosystems
Sperm Separation Devices
IVF Cabinets
Anti-vibration Tables
Witness Systems
Other
Germany In Vitro Fertilization Procedure Type Outlook (Revenue, USD Million, 2018 - 2030)
Fresh Donor
Frozen Donor
Fresh Non-donor
Frozen Non-donor
Germany In Vitro Fertilization Providers Outlook (Revenue, USD Million, 2018 - 2030)
Fertility Clinics
Hospitals & Others Setting
List of Key Companies in the Germany In Vitro Fertilization Market
Bayer AG
Cook Medical LLC
VivaNeo
Ferring B.V.
Genea Biomedx
EMD Serono, Inc. (Merck KGaA)
Merck & Co., Inc.
Thermo Fisher Scientific, Inc.
Vitrolife
"The quality of research they have done for us has been excellent..."